Winlin Dec 25 Injection

The decanoate ester prolongs the release of nandrolone, allowing for sustained therapeutic effects following intramuscular administration. Winlin Dec 25 Injection is administered via deep intramuscular injection, typically at intervals determined by the prescribing physician based on the patient’s condition and response to treatment. Caution is advised in patients with hepatic or renal impairment, cardiovascular disease, prostate hypertrophy, or breast cancer, as anabolic steroids may exacerbate these conditions.

Adverse effects can include fluid retention, hypertension, alterations in lipid profiles, virilization in females, and potential suppression of endogenous testosterone production. Regular monitoring of liver function, lipid levels, and hematocrit is recommended during therapy. Winlin Dec 25 Injection should be used under strict medical supervision to ensure appropriate dosing and to minimize the risk of adverse reactions.

It is contraindicated in pregnancy, lactation, and in patients with known hypersensitivity to nandrolone or its components.